Get the Stockscreener App
1.71
0.58%
-0.01
After Hours:
1.76
0.05
+2.92%
China Pharma Holdings Inc. stock is traded at $1.71, with a volume of 20,844.
It is down -0.58% in the last 24 hours and down -4.47% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.72
Open:
$1.71
24h Volume:
20,844
Relative Volume:
0.23
Market Cap:
$5.58M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-5.0893
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-8.31%
1M Performance:
-4.47%
6M Performance:
-21.67%
1Y Performance:
-12.76%
1-Day Range:
$1.70
$1.79
1-Week Range:
$1.70
$1.93
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.71 | 5.61M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
What is China Pharma Holdings Inc. company’s growth strategyBeginner Investor Insights Backed By Experts - jammulinksnews.com
Earnings visualization tools for PTONFree Stock Portfolio Allocation Guidance - Newser
What makes BRNS stock price move sharplyWeekly Market Direction and Sector Summary - Newser
Can a trend reversal in The Home Depot Inc. lead to recoveryBuy List With Technical Entry Triggers - Newser
What momentum shifts mean for China Pharma Holdings Inc.Risk/Reward Optimization Entry Point Analysis - Newser
Heatmap analysis for ASIX and competitorsFree Fast Return Equity Trade Forecast - Newser
How Efficient Is CAPN at Controlling Operating CostsBreakout Monitoring with Momentum Analysis - Newser
Backtesting results for GORO trading strategiesDownside Control Plan With Support Analysis - Newser
Is NEOG Stock a Good Fit for Conservative InvestorsFree Weekly Stock Opportunity Radar Scanner - Newser
What are the latest earnings results for China Pharma Holdings Inc.Smart Portfolio Strategy For Beginners - jammulinksnews.com
How institutional ownership impacts China Pharma Holdings Inc. stockFree Community Shared Smart Money Signals - Newser
Can trapped investors hope for a rebound in Alpha Modus Holdings Inc.Free Oversold Bounce Stock Play Ideas - Newser
What machine learning models say about DYCQStock Market Trend and Pattern Analysis - Newser
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Portfolio Update with ROI Focus - Newser
What institutions are buying LEGT stock nowWeekly Return Plan for Conservative Traders - Newser
Combining machine learning predictions for Prestige Wealth Inc.Early Entry Planner for Swing Candidates - Newser
How CaliberCos Inc. stock performs during market volatilityCapital Protection Strategy With Risk Analysis - Newser
Should you wait for a breakout in CRA International Inc.Historical Volatility and Pattern Breakdown Analysis - Newser
Short interest data insights for China Pharma Holdings Inc.Weekly Return Plan for Conservative Traders - Newser
How high can GNT.PR.A stock price go in 2025Downside Risk Evaluation and Stock Analysis - Newser
How Dynatrace Inc. stock performs during market volatilityMarket Correction Proof Stock Screening Analysis - Newser
LBBBR Breaks Below Key Support LevelFast Gaining Stock Screener Reports Released - metal.it
Buy Signal for LLYVA Stock Key Technical Indicators to WatchMomentum Screener with Buy and Sell Areas - Newser
Top chart patterns to watch in China Pharma Holdings Inc.Chart Driven Entry Timing for Swing Trades - Newser
Evaluating TCBK with trendline analysisSwing Watchlist With Tight Stop Placement - Newser
Signal strength of Workhorse Group Inc. stock in tech scannersFree Trade Setups With Clear Risk Limits - Newser
Using Ichimoku Cloud for China Pharma Holdings Inc. technicalsLow Risk Stock Trade Opportunity Analysis - Newser
What makes China Pharma Holdings Inc. stock price move sharplyEarly Entry Planner for Swing Candidates - Newser
TAL Education Group Depositary Receipt stock volume spike explainedLong-Term Investment Strategy Impact Analysis - Newser
How China Pharma Holdings Inc. stock performs during market volatilityDaily Breakout List with Smart Filters - Newser
Chart based exit strategy for KEQUFree Watchlist for Smart Swing Trading - Newser
How high can Lexeo Therapeutics Inc. stock price go in 2025Technical Screener for High Growth Stocks - Newser
Will RITM price bounce be sustainableLong-Term Stock Growth Forecast Insights - Newser
Using Ichimoku Cloud for Panacea Acquisition Corp. Equity Warrant technicalsBull Market Summary and Recovery Outlook - Newser
Reversal indicators forming on NVAWW stockLong-Term Stock Growth Forecast Insights - Newser
How to use Fibonacci retracement on Cisco Systems Inc.Free Trend Analysis for Safer Trades - Newser
Using economic indicators to assess ENOV potentialStrong Buy Signal Summary with Entry Zone - Newser
What makes LNZA stock price move sharplyFree Trade Setups With Clear Risk Limits - Newser
Why Flywire Corporation stock attracts strong analyst attentionEntry Zone Forecast for Momentum Trading - Newser
Key resistance and support levels for Ribbon Communications Inc.Free High Yield Stock Screening Results - Newser
Backtesting results for KEYS trading strategiesPattern Recognition Based Market Move Prediction - Newser
Will breakout in Lixte Biotechnology Holdings Inc. Equity Warrant lead to full recoverySwing Trade Entry and Exit Point Analysis - Newser
What institutions are buying BZUN stock nowInvestment Playbook for Growing Markets Shared - beatles.ru
Harris Oakmark Etf Trust Stock Support and Resistance Levels You Should KnowFree Chart Driven High Reward Trading Setup - Newser
China Pharma Holdings Inc. Recovery Hinges on Volume BreakoutTarget Return Focused Trade Insights Shared - metal.it
What institutional investors are buying NCDL stockStock Market Picks With High Returns - jammulinksnews.com
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
When is China Pharma Holdings Inc. stock expected to show significant growthFree Stock Ideas For Smart Trading - jammulinksnews.com
How many analysts rate China Pharma Holdings Inc. as a “Buy”Maximize gains with proven stock analysis - jammulinksnews.com
How strong is CRAI company’s balance sheetCapitalize on momentum-driven investment opportunities - jammulinksnews.com
Technical analysis overview for Workiva Inc. stockFree Real Time Trade Opportunity Alerts - Newser
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):